Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Hepatology 2012 (546 pages, free PDF) Hepatitis C 2012 (150 pages, free PDF)	Free Medical Books

Gynecology

Free Subscription Articles published in Br J Cancer Retrieve available abstracts of 78 articles: HTML format Text format

Single Articles

May 2012
1. OPDAHL S , Romundstad PR, Alsaker MD, Vatten LJ, et al
   Hypertensive diseases in pregnancy and breast cancer risk.
   Br J Cancer. 2012 May 10. doi: 10.1038/bjc.2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. TAYLOR SE , Green JA
   Towards individualisation of treatment in endometrial cancer.
   Br J Cancer. 2012;106:1581-2.
   PubMed     Text format     Related articles   
   
   
   
   
3. SIMS AH , Zweemer AJ, Nagumo Y, Faratian D, et al
   Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer.
   Br J Cancer. 2012 May 1. doi: 10.1038/bjc.2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. STALBERG K , Svensson T, Granath F, Kieler H, et al
   Evaluation of prevalent and incident ovarian cancer co-morbidity.
   Br J Cancer. 2012 May 1. doi: 10.1038/bjc.2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   April 2012
5. BELLONE S , Roque D, Cocco E, Gasparrini S, et al
   Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy.
   Br J Cancer. 2012;106:1543-50.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. SCHREVEL M , Karim R, Ter Haar NT, van der Burg SH, et al
   CXCR7 expression is associated with disease-free and disease-specific survival in cervical cancer patients.
   Br J Cancer. 2012;106:1520-5.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. PATEL A , Galaal K, Burnley C, Faulkner K, et al
   Cervical cancer incidence in young women: a historical and geographic controlled UK regional population study.
   Br J Cancer. 2012 Apr 24. doi: 10.1038/bjc.2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. LAJER CB , Garnaes E, Friis-Hansen L, Norrild B, et al
   The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer.
   Br J Cancer. 2012 Apr 3. doi: 10.1038/bjc.2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   March 2012
9. BURGER EA , Ortendahl JD, Sy S, Kristiansen IS, et al
   Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway.
   Br J Cancer. 2012 Mar 22. doi: 10.1038/bjc.2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. OSHER DJ , De Leeneer K, Michils G, Hamel N, et al
    Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families.
    Br J Cancer. 2012 Mar 13. doi: 10.1038/bjc.2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. LOMNYTSKA MI , Becker S, Gemoll T, Lundgren C, et al
    Impact of genomic stability on protein expression in endometrioid endometrial cancer.
    Br J Cancer. 2012 Mar 13. doi: 10.1038/bjc.2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. POPPLE A , Durrant LG, Spendlove I, Rolland P, et al
    The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer.
    Br J Cancer. 2012 Mar 13. doi: 10.1038/bjc.2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. KRAKSTAD C , Trovik J, Wik E, Engelsen IB, et al
    Loss of GPER identifies new targets for therapy among a subgroup of ERalpha-positive endometrial cancer patients with poor outcome.
    Br J Cancer. 2012 Mar 13. doi: 10.1038/bjc.2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. FALLOWFIELD LJ , Kilburn LS, Langridge C, Snowdon CF, et al
    Long-term assessment of quality of life in the Intergroup Exemestane Study: 5 years post-randomisation.
    Br J Cancer. 2012;106:1062-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2012
15. AGARWAL R , Harding V, Short D, Fisher RA, et al
    Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia.
    Br J Cancer. 2012 Feb 28. doi: 10.1038/bjc.2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. KOCKEN M , Berkhof J, van Kemenade FJ, Louwers JA, et al
    Long-term CIN3+ risk in women with abnormal cytology; role of hrHPV testing.
    Br J Cancer. 2012;106:817-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. BONO Y , Kyo S, Takakura M, Maida Y, et al
    Creation of immortalised epithelial cells from ovarian endometrioma.
    Br J Cancer. 2012 Feb 21. doi: 10.1038/bjc.2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. SEEBACHER V , Polterauer S, Grimm C, Rahhal J, et al
    Prognostic significance of gamma-glutamyltransferase in patients with endometrial cancer: a multi-centre trial.
    Br J Cancer. 2012 Feb 7. doi: 10.1038/bjc.2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2012
19. ROYER B , Kalbacher E, Onteniente S, Jullien V, et al
    Intraperitoneal clearance as a potential biomarker of cisplatin after intraperitoneal perioperative chemotherapy: a population pharmacokinetic study.
    Br J Cancer. 2012;106:460-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. VAN DEN EINDEN LC , Grefte JM, van der Avoort IA, Vedder JE, et al
    Cytology of the vulva: feasibility and preliminary results of a new brush.
    Br J Cancer. 2012;106:269-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. RIJKAART DC , Berkhof J, van Kemenade FJ, Coupe VM, et al
    HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications.
    Br J Cancer. 2012 Jan 17. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. ALEXANDRE J , Brown C, Coeffic D, Raban N, et al
    CA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: experience of the GCIG CALYPSO trial.
    Br J Cancer. 2012 Jan 12. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. COLEY HM , Safuwan NA, Chivers P, Papacharalbous E, et al
    The cyclin-dependent kinase inhibitor p57(Kip2) is epigenetically regulated in carboplatin resistance and results in collateral sensitivity to the CDK inhibitor seliciclib in ovarian cancer.
    Br J Cancer. 2012 Jan 10. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. BLANK MM , Wentzensen N, Murphy MA, Hollenbeck A, et al
    Dietary fat intake and risk of ovarian cancer in the NIH-AARP Diet and Health Study.
    Br J Cancer. 2012 Jan 5. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. CASTANON A , Tristram A, Mesher D, Powell N, et al
    Effect of diindolylmethane supplementation on low-grade cervical cytological abnormalities: double-blind, randomised, controlled trial.
    Br J Cancer. 2012;106:45-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
26. SIDON L , Ingham S, Clancy T, Clayton R, et al
    Uptake of risk-reducing salpingo-oophorectomy in women carrying a BRCA1 or BRCA2 mutation: evidence for lower uptake in women affected by breast cancer and older women.
    Br J Cancer. 2011 Dec 20. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. TAYLOR-HARDING B , Agadjanian H, Nassanian H, Kwon S, et al
    Indole-3-carbinol synergistically sensitises ovarian cancer cells to bortezomib treatment.
    Br J Cancer. 2011 Dec 13. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. CHEREAU E , Feron JG, Ballester M, Coutant C, et al
    Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2-IIB cervical cancer.
    Br J Cancer. 2011 Dec 6. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. PARKIN DM
    15. Cancers attributable to reproductive factors in the UK in 2010.
    Br J Cancer. 2011;105 Suppl 2:S73-6.
    PubMed     Text format     Related articles   
    
    
    
    
30. PARKIN DM
    10. Cancers attributable to exposure to hormones in the UK in 2010.
    Br J Cancer. 2011;105 Suppl 2:S42-8.
    PubMed     Text format     Related articles   
    
    
    
    
31. PARKIN DM
    9. Cancers attributable to inadequate physical exercise in the UK in 2010.
    Br J Cancer. 2011;105 Suppl 2:S38-41.
    PubMed     Text format     Related articles   
    
    
    
    November 2011
32. KABAT GC , Kim MY, Strickler HD, Shikany JM, et al
    A longitudinal study of serum insulin and glucose levels in relation to colorectal cancer risk among postmenopausal women.
    Br J Cancer. 2011 Nov 29. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. GOEBEL G , Berger R, Strasak AM, Egle D, et al
    Elevated mRNA expression of CHAC1 splicing variants is associated with poor outcome for breast and ovarian cancer patients.
    Br J Cancer. 2011 Nov 22. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. MCMEEKIN S , Patel R, Verschraegen C, Celano P, et al
    Phase I/II study of sagopilone (ZK-EPO) plus carboplatin in women with recurrent platinum-sensitive ovarian cancer.
    Br J Cancer. 2011 Nov 22. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. BRAICU EI , Sehouli J, Richter R, Pietzner K, et al
    Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers.
    Br J Cancer. 2011 Nov 1. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
36. HINTEN F , van den Einden LC, Hendriks JC, van der Zee AG, et al
    Risk factors for short- and long-term complications after groin surgery in vulvar cancer.
    Br J Cancer. 2011;105:1279-87.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. HOFSTETTER G , Berger A, Schuster E, Wolf A, et al
    Delta133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer.
    Br J Cancer. 2011 Oct 18. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. KAJIYAMA H , Shibata K, Mizuno M, Umezu T, et al
    Long-term survival of young women receiving fertility-sparing surgery for ovarian cancer in comparison with those undergoing radical surgery.
    Br J Cancer. 2011 Oct 4. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
39. ZELENIUCH-JACQUOTTE A , Shore RE, Afanasyeva Y, Lukanova A, et al
    Postmenopausal circulating levels of 2- and 16alpha-hydroxyestrone and risk of endometrial cancer.
    Br J Cancer. 2011 Sep 27. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. ARBYN M , Roelens J, Martin-Hirsch P, Leeson S, et al
    Use of HC2 to triage women with borderline and mild dyskaryosis in the UK.
    Br J Cancer. 2011;105:877-80.
    PubMed     Text format     Related articles   
    
    
    
    
41. KAPP DS , Kiet TK, Chan JK
    Prognostic discrimination of subgrouping node-positive endometrioid uterine cancer: location vs nodal extent.
    Br J Cancer. 2011 Sep 13. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. BUCK K , Zaineddin AK, Vrieling A, Heinz J, et al
    Estimated enterolignans, lignan-rich foods, and fibre in relation to survival after postmenopausal breast cancer.
    Br J Cancer. 2011 Sep 13. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. LEE CK , Simes RJ, Brown C, Lord S, et al
    Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer.
    Br J Cancer. 2011 Sep 13. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. TSILIDIS KK , Allen NE, Key TJ, Dossus L, et al
    Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition.
    Br J Cancer. 2011 Sep 13. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. TODESCHINI P , Cocco E, Bellone S, Varughese J, et al
    Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumab.
    Br J Cancer. 2011 Sep 13. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. BOCKELMAN C , Lassus H, Hemmes A, Leminen A, et al
    Prognostic role of CIP2A expression in serous ovarian cancer.
    Br J Cancer. 2011 Sep 6. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. KELLY RS , Patnick J, Kitchener HC, Moss SM, et al
    HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study.
    Br J Cancer. 2011 Sep 6. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
48. RAJA FA , Griffin CL, Qian W, Hirte H, et al
    Initial toxicity assessment of ICON6: a randomised trial of cediranib plus chemotherapy in platinum-sensitive relapsed ovarian cancer.
    Br J Cancer. 2011 Aug 30. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. ZANG RY , Harter P, Chi DS, Sehouli J, et al
    Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort.
    Br J Cancer. 2011 Aug 30. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. SUTCLIFFE S , Nevin RL, Pakpahan R, Elliott DJ, et al
    Prostate involvement during sexually transmitted infections as measured by prostate-specific antigen concentration.
    Br J Cancer. 2011;105:602-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. KOSMAS C , Vorgias G, Tsakonas G, Politis P, et al
    Paclitaxel-ifosfamide-carboplatin combination chemotherapy regimen in advanced uterine and adnexal malignant mixed Mullerian tumours.
    Br J Cancer. 2011 Aug 16. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. DHILLON PK , Yeole BB, Dikshit R, Kurkure AP, et al
    Trends in breast, ovarian and cervical cancer incidence in Mumbai, India over a 30-year period, 1976-2005: an age-period-cohort analysis.
    Br J Cancer. 2011 Aug 9. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. MARLOW LA
    HPV vaccination among ethnic minorities in the UK: knowledge, acceptability and attitudes.
    Br J Cancer. 2011;105:486-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. GYLLENSTEN U , Sanner K, Gustavsson I, Lindell M, et al
    Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer.
    Br J Cancer. 2011 Aug 2. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
55. IIDA K , Nakayama K, Rahman MT, Rahman M, et al
    EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target.
    Br J Cancer. 2011;105:420-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. MAHDI H , Swensen RE, Hanna R, Kumar S, et al
    Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumour of the ovary.
    Br J Cancer. 2011 Jul 19. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. KEY TJ , Appleby PN, Reeves GK, Roddam AW, et al
    Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies.
    Br J Cancer. 2011 Jul 19. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. LEE CK , Gurney H, Brown C, Sorio R, et al
    Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer.
    Br J Cancer. 2011 Jul 12. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. PEASLAND A , Wang LZ, Rowling E, Kyle S, et al
    Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines.
    Br J Cancer. 2011 Jul 5. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
60. VAN GORP T , Timmerman D, Vergote I
    Reply: The performance of the risk of ovarian malignancy algorithm.
    Br J Cancer. 2011;105:187-8.
    PubMed     Text format     Related articles   
    
    
    
    
61. LANGMAR Z , Nemeth M, Szekely B, Borgulya G, et al
    The performance of the risk of ovarian malignancy algorithm.
    Br J Cancer. 2011;105:185-6.
    PubMed     Text format     Related articles   
    
    
    
    
62. JULIN B , Wolk A, Akesson A
    Dietary cadmium exposure and risk of epithelial ovarian cancer in a prospective cohort of Swedish women.
    Br J Cancer. 2011 Jun 21. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. VAN DER GUN BT , de Groote ML, Kazemier HG, Arendzen AJ, et al
    Transcription factors and molecular epigenetic marks underlying EpCAM overexpression in ovarian cancer.
    Br J Cancer. 2011 Jun 21. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. CHALLBERG J , Ashcroft L, Lalloo F, Eckersley B, et al
    Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRT.
    Br J Cancer. 2011 Jun 7. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. SABATIER R , Finetti P, Bonensea J, Jacquemier J, et al
    A seven-gene prognostic model for platinum-treated ovarian carcinomas.
    Br J Cancer. 2011 Jun 7. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. FOLEY G , Alston R, Geraci M, Brabin L, et al
    Increasing rates of cervical cancer in young women in England: an analysis of national data 1982-2006.
    Br J Cancer. 2011 Jun 7. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
67. CASTELLSAGUE X , Munoz N, Pitisuttithum P, Ferris D, et al
    End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. JOHNSON N , Miles T, Bailey D, Tylko-Hill K, et al
    Delays in treating endometrial cancer in the South West of England.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
69. EVANS T , Sany O, Pearmain P, Ganesan R, et al
    Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006.
    Br J Cancer. 2011;104:1505-10.
    PubMed     Text format     Related articles   
    
    
    
    
70. WALKINGTON L , Webster J, Hancock BW, Everard J, et al
    Hyperthyroidism and human chorionic gonadotrophin production in gestational trophoblastic disease.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
71. MA YT , Collins SI, Young LS, Murray PG, et al
    Smoking initiation is followed by the early acquisition of epigenetic change in cervical epithelium: a longitudinal study.
    Br J Cancer. 2011;104:1500-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. BRUNING-RICHARDSON A , Bond J, Alsiary R, Richardson J, et al
    ASPM and microcephalin expression in epithelial ovarian cancer correlates with tumour grade and survival.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. VOSS MA , Gordon N, Maloney S, Ganesan R, et al
    Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. DUIKER EW , Meijer A, van der Bilt AR, Meersma GJ, et al
    Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis.
    Br J Cancer. 2011;104:1278-87.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. BERNATSKY S , Ramsey-Goldman R, Foulkes WD, Gordon C, et al
    Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. BIGNOTTI E , Ragnoli M, Zanotti L, Calza S, et al
    Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
77. HALL JS , Leong HS, Armenoult LS, Newton GE, et al
    Exon-array profiling unlocks clinically and biologically relevant gene signatures from formalin-fixed paraffin-embedded tumour samples.
    Br J Cancer. 2011;104:971-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
78. SZAREWSKI A , Cadman L, Mesher D, Austin J, et al
    HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: